Thursday, October 28, 2021
اُردُو نیوز Newspaper Live-TV(UK) Live-TV(PK)
اُردُو نیوز Newspaper
Live-TV(UK) Live-TV(PK)

Collegium Pharma's opioid painkiller wins US approval

Collegium Pharma's opioid painkiller wins US approval
April 27, 2016
MASSACHUSETTS - Collegium Pharmaceutical Inc said on Tuesday its abuse-deterrent painkiller won full marketing approval from US health regulators. The drug, Xtampza ER, won a tentative approval in November, but full approval was contingent on the outcome of a lawsuit filed by Purdue Pharma against Collegium. Purdue Pharma, which has also developed abuse-deterrent versions of the commonly prescribed and often-abused painkiller Oxycontin, claimed that Xtampza infringed some of its patents. However, the District Court of Massachusetts in February ruled in favor of Collegium. Xtampza ER is a long-acting oral opioid painkiller meant to be taken after a meal for maximum effect. -Reuters
تازہ ترین خبریں حاصل کرنے کے لیے فوری اطلاع کی اجازت دیں

آپ کسی بھی وقت دائیں طرف نیچے بیل آئیکن پر صرف ایک کلک کے ذریعے آسانی سے سبسکرائب کر سکتے ہیں۔